Buy & Sell ACADIA Pharmaceuticals Inc. (ACAD) – ACADIA Pharmaceuticals Inc. Price Today
Aura AI Summary
Key Stats
- $3.61BMarket Cap
- HealthSector
- -18.78%3M Drawdown
- $2.81BEnterprise Value
- -Dividend Yield
- 74 daysTypical Hold Time
ACADIA Pharmaceuticals Inc. (ACAD) is currently valued at a market capitalization of $3.61B, with an enterprise value of $2.81B. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $20.06 and a high of $28.06, highlighting its annual price range. Over the past three months, ACADIA Pharmaceuticals Inc. has recorded a drawdown of -18.78%, reflecting recent price volatility. On average, investors hold ACADIA Pharmaceuticals Inc. for approximately 74 days, indicating typical investor behavior on the platform.
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Most Recent News
Canada's new digital regulations risk stifling innovation and driving tech firms to the US, warns Yanik Guillemette.
Yanik Guillemette, a Canadian tech entrepreneur, criticizes Ottawa's increasing digital regulations, including a proposed 15% revenue tax on streaming platforms and laws C-11, C-18, and C-22. He argues these measures burden the tech ecosystem, raise ...

Canadian digital regulations risk driving tech innovation and investment out of the country, warns expert.
Yanik Guillemette, a Montreal-based entrepreneur and investment strategist, criticizes Canada's growing digital regulations, including the CRTC's proposal for streaming platforms to fund Canadian content. He argues these rules increase costs for cons...

Trump says Iran nuclear talks are progressing orderly, urges patience and keeps naval blockade until deal is done.
President Donald Trump stated that negotiations with Iran over its nuclear program are proceeding in an orderly and constructive manner. He emphasized the need for patience and warned against rushing the deal, maintaining the U.S. naval blockade on I...
